![](/wp-content/themes/basic-child/images/print.png)
Equine Lyme
![horse-5628882_1280 horse-5628882_1280](https://lymediseaseassociation.org/wp-content/uploads/2024/02/horse-5628882_1280.jpg)
EquiManagement published the Disease Du Jour podcast, “Ep. 126: Lyme Disease with Dr. Toby Pinn-Woodcock.” In this podcast, Dr. Pinn-Woodcock, DVM, DACVIM, provides a broad overview of Lyme disease in equines.
EquiManagement published the Disease Du Jour podcast, “Ep. 126: Lyme Disease with Dr. Toby Pinn-Woodcock.” In this podcast, Dr. Pinn-Woodcock, DVM, DACVIM, provides a broad overview of Lyme disease in equines.
The 19th Vector Control Advisory Group (VCAG) of the World Health Organization (WHO) meeting took place from 09.27/28.2023. The meeting was co-chaired by Dr. Audrey Lenhart and Dr. Leanne Robinson. A report summarizes the proceedings and outcomes of the meeting. VCAG provided feedback and advice to applicants who had made submissions relating to the following interventions, including systemic endectocide treatment for Lyme disease.
Harvard Magazine’s, Jonathan Shaw, 01/02. 2024, published “Deciphering Lyme Disease.” Shaw describes the work of Jacob Lemieux, assistant professor of medicine at Harvard University that began in 2017. The project of whole-genome sequencing of hundreds of samples of Borrelia burgdorferi took nearly 6 years. Findings from this study has illuminated the reasons why people experience such variable severity of illness, and why these variabilities in individuals are also variable by geography.
We miss you, TC
Over the decades, I have been fortunate to work with some of the finest people I have ever known. These are the people who have been fighting against influential individuals preventing the diagnosis and treatment of thousands of Lyme patients—instead of working for those who have helped provide or enable treatment.
The People’s Pharmacy, Terry Graedon, (01.04.2024) published “How Informed Are Patients Who Sign Consent Forms?” In this article, the author investigates how consent forms work, or fail, to inform patients of the risks of particular procedures/treatments. The author found that according to a JAMA Internal Medicine (12.11.2023) analysis of more than 100 hospital procedure consent forms, the majority were composed of complex language that might prove difficult for general patient understanding.
MassLive, Greta Jochem, 1.3.2024, reports on “Lawsuit over at-home Lyme disease test gets dismissed after settlement.” This article reports on the dismissal of a class action lawsuit against LetsGetChecked, a company offering an at-home Lyme disease test. The lawsuit was filed in Jun by a Western Massachusetts woman and TruthCures, a Kansas-based nonprofit group, claiming that the tests were deceptive and inaccurate. The case was voluntarily dismissed with prejudice by the filers, meaning it cannot be brought again in the future, following a confidential settlement.
The terms of the settlement are undisclosed. However, LetsGetChecked has agreed to “never ever again sell Lyme diagnosis tests directly to consumers.” Currently, the tests are listed as out of stock on their online store. The company, based in New York and Dublin, did not comment on the case.
GlobeNewswire, Sixty Degrees Pharmaceuticals, 12.26.2023, reports on “60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024.” This article from 60 Degrees Pharmaceuticals, Inc. highlights several key updates and developments regarding their investigational drug, tafenoquine, for the treatment of babesiosis, an emerging tick-borne disease. Babesiosis is a potentially life-threatening tick-borne illness on the rise in the United States, estimated to affect around 47,000 individuals annually. It’s often found in areas where Lyme disease is prevalent and can be transmitted through tick bites or contaminated blood transfusions.
Children’s National Hospital – Congenital Infection Program has launched a pilot study being led by Sarah Mulkey, MD, PhD, “Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure.” […]
In the 2023 Impact Report, Johns Hopkins Medicine – Lyme Disease Research Center has announced that they have been awarded National Institutes for Health (NIH) R01 funding to study post-treatment Lyme disease. This R01 involves five different departments at Johns Hopkins Medicine: Neurology, Psychiatry, Rheumatology, Physical Medicine and Rehabilitation, and Radiology, which highlights the value of a multidisciplinary approach to understanding the biology of Lyme disease.
Fox News, Melissa Rudy, 12.10.2023, reports on “Deadly Rocky Mountain spotted fever outbreak in California likely came from Mexico, CDC says.” The Centers for Disease Control and Prevention (CDC) issued a health advisory on 12.08.2023 advising of an outbreak of Rocky Mountain spotted fever (RMSF) southern California which has hospitalized five people and resulted in three deaths between late July and December 2023.
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.
Some providers may not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. Contact the provider to confirm.
It is your responsibility to contact the provider’s office to confirm the current address, directions, nature of services provided, and all other provider information before you make an appointment.
DISCLAIMER: The Lyme Disease Association, Inc. provides referrals to health care providers who treat Lyme disease, and often other TBD, as a courtesy to those seeking Lyme Literate Physicians (LLMD). However, some of the providers included do not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. We do not evaluate the professional competence or qualifications of health care providers on our referral list or the costs of services provided. Accordingly, the LDA neither warrants nor endorses the health care providers contained on this list nor the quality of care you will receive from those providers. We do not make recommendations, only referrals. LDA does not receive any monies from physicians to be included on this list nor does LDA provide any monies to physicians. Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines: Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the Doctor Referral System contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the zip code entered and category/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of.
LDA does not accept or reply to any comments on:
We cannot guarantee that the information provided will be timely and accurate or that physicians on the list are accepting new patients, or that they accept insurance. The selection of a physician should be made by you after careful consideration. There are two approaches in the treatment of Lyme disease. Our list contains physicians who generally follow more flexible treatment approaches than those advocated by the Infectious Diseases Society of America (IDSA). LDA is not responsible for incorrect information on the website. BEFORE DOCTOR VISIT: Please contact the physicians’ offices directly to confirm their current address, directions, and any other necessary information before scheduling an appointment. Do not rely only on the maps provided on this site. The maps on LDA’s Doctor Referral System are for informational purposes and provide an approximate locality of the listing based on the addresses we are provided with at the time of site updates. Practitioners often relocate and addresses can change. Notification of changes in listed information can be updated on our Dr. Referral Contact Form. Thank you, Lyme Disease Association, Inc. (LDA)
Subscriber information will not be shared outside of the Lyme Disease Association, Inc. nor used for donor solicitation.
The Lyme Disease Association, Inc. reserves the right to unsubscribe anyone from this service without cause.